Prolonged presence of viral nucleic acid in clinically recovered COVID-19 patients was not associated with effective infectiousness

Emerg Microbes Infect. 2020 Dec;9(1):2315-2321. doi: 10.1080/22221751.2020.1827983.

Abstract

Prolonged presence of viral nucleic acid was reported in certain patients with coronavirus disease 2019 (COVID-19), with unclear clinical and epidemiological significance. We here described the clinical and epidemiological characteristics of 37 recovered COVID-19 patients with prolonged presence of viral RNA in Wuhan, China. For those who had been discharged and re-admitted, their close contacts outside the hospital were traced and evaluated. The median age of the 37 patients was 62 years (IQR 50, 68), and 24 (64.9%) were men. They had common or severe COVID-19. With prolonged positive RT-PCR, most patients were clinically stable, 29 (78.4%) denied any symptoms. A total of 431 PCR tests were carried out, with each patient at a median of 8 time points. The median time of PCR positivity to April 18 was 78 days (IQR 67.7, 84.5), and the longest 120 days. 22 of 37 patients had been discharged at a median of 44 days (IQR 22.3, 50) from disease onset, and 9 had lived with their families without personal protections for a total of 258 person-days and no secondary infection was identified through epidemiological investigation, nucleic acid and antibody screening. Infectiousness in COVID-19 patients with prolonged presence of viral nucleic acid should not solely be evaluated by RT-PCR. Those patients who have clinically recovered and whose disease course has exceeded four weeks were associated with very limited infectiousness. Reconsideration of disease control in such patients is needed.

Keywords: COVID-19; SARS-CoV-2; infectiousness; prolonged viral RNA presence; secondary transmission.

MeSH terms

  • Aged
  • Betacoronavirus / genetics
  • Betacoronavirus / physiology*
  • COVID-19
  • China / epidemiology
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / virology*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / virology*
  • Polymerase Chain Reaction
  • RNA, Viral / genetics*
  • RNA, Viral / metabolism
  • SARS-CoV-2

Substances

  • RNA, Viral